# Cancer Research and Treatment

**Type:** Journals  
**Canonical URL:** https://scholariq.org/journals/cancer-research-and-treatment/

## Facts

| Field | Value |
| --- | --- |
| Open Access | true |
| ISSN-L | 1598-2998 |
| ISSNs | 1598-2998,2005-9256 |
| OpenAlex ID | https://openalex.org/S21122719 |
| Publisher | Korean Cancer Association |

## Journal papers

- [PD-L1 Testing in Gastric Cancer by the Combined Positive Score of the 22C3 PharmDx and SP263 Assay with Clinically Relevant Cut-offs](https://scholariq.org/papers/pd-l1-testing-in-gastric-cancer-by-the-combined-positive-score-of-the-22c3/)
- [Incidence and Survival of Childhood Cancer in Korea](https://scholariq.org/papers/incidence-and-survival-of-childhood-cancer-in-korea/)
- [The Association of Acquired T790M Mutation with Clinical Characteristics after Resistance to First-Line Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor in Lung Adenocarcinoma](https://scholariq.org/papers/the-association-of-acquired-t790m-mutation-with-clinical-characteristics-after/)
- [Bevacizumab Plus Erlotinib Combination Therapy for Advanced Hereditary Leiomyomatosis and Renal Cell Carcinoma-Associated Renal Cell Carcinoma: A Multicenter Retrospective Analysis in Korean Patients](https://scholariq.org/papers/bevacizumab-plus-erlotinib-combination-therapy-for-advanced-hereditary/)
- [CXCL-13 Regulates Resistance to 5-Fluorouracil in Colorectal Cancer](https://scholariq.org/papers/cxcl-13-regulates-resistance-to-5-fluorouracil-in-colorectal-cancer/)
- [Association of Immune-Related Adverse Events and the Efficacy of Anti–PD-(L)1 Monotherapy in Non–Small Cell Lung Cancer: Adjusting for Immortal-Time Bias](https://scholariq.org/papers/association-of-immune-related-adverse-events-and-the-efficacy-of-anti-pd-l-1/)
- [Outcomes of Anti-CD19 CAR-T Treatment of Pediatric B-ALL with Bone Marrow and Extramedullary Relapse](https://scholariq.org/papers/outcomes-of-anti-cd19-car-t-treatment-of-pediatric-b-all-with-bone-marrow-and/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.